製薬産業向け治験サプライ及び物流の世界市場2016-2026...市場調査レポートについてご紹介

【英文タイトル】Clinical Trial Supply and Logistics Market for Pharma 2016-2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Overview of the World Market for Clinical Trial Supply and Logistics
1.2 Benefits of This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Related Reports
1.9 About Visiongain

2. Defining the Clinical Trial Supply and Logistics Market
2.1 An Introduction to the Clinical Trial Supply and Logistics Market
2.2 Clinical Trials are Becoming Increasingly Complex
2.3 Clinical Trial Globalisation: Access to New Markets and New Patients
2.4 Outsourcing Clinical Trial Supply and Logistics
2.5 What Services Are Most Commonly Outsourced?
2.6 Which Companies Participate in the Clinical Trial Supply and Logistics Market?
2.7 Clinical Trial Supply and Logistics: Trends and Future Outlook

3. Clinical Trial Supply and Logistics: World Market Outlook and Forecasting 2016-2026
3.1 The World Clinical Trial Supply and Logistics Market 2015
3.1.1 Which Were the Leading Market Sectors in 2015?
3.2 The World Clinical Trial Supply and Logistics Market Forecast 2016-2026
3.2.1 What Will Drive Market Growth to 2026?
3.2.2 Clinical Trial Supply and Logistics: Market Restraints 2016-2026
3.3 Clinical Trial Manufacturing Submarket 2016-2026
3.3.1 Outlook and Forecast for the Clinical Trial Manufacturing Submarket 2016-2026
3.3.2 Complex Manufacturing and Packaging to Drive Growth 2016-2026
3.3.3 Clinical Trial Packaging Submarket Forecast 2016-2026
3.4 Clinical Trial Logistics and Distribution Submarket 2016-2026
3.4.1 Clinical Trial Logistics and Distribution Submarket Forecast 2016-2026
3.4.2 Clinical Trial Logistics and Distribution: Drivers and Restraints 2016-2026
3.4.3 Clinical Trial Cold Chain Distribution Submarket Forecast 2016-2026
3.5 Clinical Trial Supply Chain Management Submarket 2016-2026
3.5.1 Clinical Trial Supply Chain Management Submarket Forecast 2016-2026
3.5.2 Drivers and Restraints for the Clinical Trial Supply Chain Management Submarket 2016-2026

4. Leading National Markets for Clinical Trial Supply and Logistics 2016-2026
4.1 Defining National Submarkets for Clinical Trial Supply and Logistics
4.2 Leading National Submarkets for Clinical Trial Supply and Logistics 2015
4.2.1 How Will These Leading Submarkets Grow 2016-2026?
4.3 The US: Clinical Trial Supply and Logistics Market, 2016-2026
4.3.1 How Will Demand for Clinical Trial Logistics Grow in the US to 2026?
4.4 EU5 Markets for Clinical Trial Supply and Logistics, 2016-2026
4.4.1 Germany: Clinical Trial Supply and Logistics Market, 2016-2026
4.4.2 France: Clinical Trial Supply and Logistics Market, 2016-2026
4.4.3 The UK: Clinical Trial Supply and Logistics Market, 2016-2026
4.4.4 Italy: Clinical Trial Supply and Logistics Market, 2016-2026
4.4.5 Spain: Clinical Trial Supply and Logistics Market, 2016-2026
4.5 Japan: A New and Growing Market for Outsourced Logistics
4.5.1 Japanese Clinical Trial Supply and Logistics Market, 2016-2026
4.6 Clinical Trials Increasing Demand in Emerging National Markets
4.7 China: Clinical Trial Supply and Logistics Market, 2016-2026
4.7.1 Foreign Investment in Chinese Clinical Trial Logistics
4.7.2 Strong Growth for Clinical Trial Supply and Logistics in China 2016-2026
4.8 India: An Emerging Destination for Outsourced Clinical Trials
4.8.1 New Clinical Trial Rules Restrain Growth in 2015
4.8.2 India: Clinical Trial Supply and Logistics Market, 2016-2026
4.9 The Latin American Clinical Trial Supply and Logistics Market
4.9.1 Challenging Distribution Conditions
4.9.2 Brazil: Clinical Trial Supply and Logistics Market, 2016-2026
4.10 Russia: Clinical Trial Supply and Logistics Market, 2016-2026
4.10.1 Russia Benefiting From Close Proximity to European Union
4.10.2 Outsourcing Will Grow Strongly in Russia

5. Clinical Trial Supply and Logistics: Regulatory Outlook 2016-2026
5.1 How do Regulatory Standards Affect Clinical Trial Supply?
5.1.1 Good Practices (GxP) in Clinical Trial Distribution
5.1.1.1 Good Manufacturing Practice (GMP)
5.1.1.2 Good Distribution Practice (GDP)
5.1.2 Import Regulations Complicate International Manufacturing and Trials
5.2 Clinical Trial Supply Regulations in the US 2015
5.2.1 Importing Drugs into the US: A Reinterpretation of the Rules
5.3 Clinical Trial Regulations in the EU 2015
5.3.1 Manufacturing Requirements for Clinical Trial Materials in the EU
5.3.2 The European Commission Releases New GDP Guidelines 2013
5.4 GMP and Importation Regulations for Pharmaceuticals in Japan 2015
5.5 Clinical Trial Supply Chain Regulations in Emerging Markets
5.5.1 China: Tougher Regulations for Pharmaceutical Companies and Service Providers
5.5.1.1 Improving Supply Chain Security in China 2015
5.5.2 India: Drug Manufacturing and Imports for Clinical Trials
5.5.2.1 The CDSCO Drafts New GDP Guidelines
5.5.3 Brazil: Slow Regulatory Approval for Clinical Trials
5.5.4 Recent Updates to Pharmaceutical Regulation in Russia

6. Clinical Trial Supply and Logistics: Industry Trends 2016-2026
6.1 Clinical Trial Supply and Logistics Market: Strengths and Weaknesses 2015
6.2 Clinical Trial Supply and Logistics Market: Opportunities and Threats 2016-2026
6.3 Clinical Trial Supply and Logistics Market: STEP Analysis 2016-2026
6.3.1 Social Factors
6.3.2 How Will Novel Technologies Affect the Market to 2026?
6.3.3 Economic Pressures: Demands for Lower Cost Trials and Logistics
6.3.4 Political Issues
6.4 Securing the Clinical Trial Supply Chain 2016-2026
6.4.1 How Will Technology Improve Supply Chain Security?
6.5 How Will Clinical Trial Globalisation Impact Supply and Logistics?
6.6 Trends in Clinical Trial Manufacturing 2016-2026
6.6.1 The Challenge of Comparator Sourcing for Clinical Trials
6.6.1.1 Comparators Are a Source of Risk for Supply Chain Security
6.6.1.2 Regulators and Payers Will Increasingly Demand Comparative Effectiveness Research
6.6.2 Trends in Packaging for Clinical Trials 2016-2026
6.7 Clinical Trial Supply Chain Management Trends to 2026
6.7.1 Forecasting and Modelling to Ensure Sufficient Supply
6.7.2 IT Systems Improve Clinical Trial Planning: IVRS and IWRS
6.7.3 Home-Based Trial Participation: Opportunities and Challenges for Logistics
6.7.4 How Will Greater Use of Adaptive Clinical Trials Impact Trial Logistics?
6.8 Outsourcing Clinical Trial Supply and Logistics
6.8.1 Managing Multiple Supplier Networks

7. The Rise of Cold Chain Logistics in Clinical Trials 2016-2026
7.1 An Introduction to Cold Chain Supply and Distribution
7.1.1 The Importance of Cold Chain for Clinical Trials
7.1.2 Maintaining the Cold Chain
7.2 The Regulatory Outlook for Cold Chain Logistics
7.2.1 International Air Transport Regulations and Guidance: The Temperature Sensitive Label
7.3 Cold Chain Will Account for an Increasing Proportion of Clinical Trial Logistics 2016-2026
7.3.1 Biologic Drug Development Will Stimulate Demand
7.3.1.1 Emerging Trends in Biological Drug Development
7.3.2 Pharma Cold Chain Logistics in Emerging Markets
7.4 The Role of Technology in Clinical Cold Chain Logistics
7.4.1 Active and Passive Temperature Control
7.4.2 There Are Many Ways to Maintain Temperature in the Cold Chain
7.4.2.1 Developments in Phase Change Materials
7.4.2.2 The Benefits of Liquid Nitrogen for Sample Transportation
7.4.3 Advances in RFID for Temperature Monitoring
7.4.3.1 Will Uptake for RFID Grow Among Biopharma Companies to 2026?
7.4.4 Future Technologies for Cold Chain Supply Management
7.4.4.1 Demand for Reusable Cold Chain Packaging

8. Clinical Trial Supply and Logistics Market: Leading Companies
8.1 Third Party Logistics Providers: Leading Clinical Distributors
8.1.1 World Courier: A Pharmaceutical Supply Specialist
8.1.1.1 Distribution Services for Pharma, CROs and Central Laboratories
8.1.1.2 World Courier Is the Clinical Trial Distribution Market Leader
8.1.1.3 World Courier Service Expansion: New Facility Opened at Melbourne, Australia
8.1.2 DHL: A Global Leader in Supply Chain Logistics
8.1.2.1 Life Sciences: A Fast-Growing Source of Revenue for DHL Supply Chain
8.1.2.2 DHL Adds New Services for Healthcare and Clinical Trial Clients 2015
8.1.3 Marken: A leader in Direct to Patient Services
8.1.3.1 What Services Does Marken Offer Clinical Trial Sponsors?
8.1.3.2 Marken: Challenging Market Conditions 2010-2015
8.1.3.3 Marken Continues to Expand Worldwide
8.1.3.4 Expertise in Biological Sample Management
8.1.4 Other Leading and Emerging Players in the Market 2015
8.1.4.1 TNT Express
8.1.4.2 FedEx
8.1.4.3 Movianto – A European Healthcare Specialist
8.2 Clinical Trial Manufacturing: Submarket Leaders
8.2.1 Catalent Pharma Solutions
8.2.1.1 Clinical Trial Manufacturing and Supply Services
8.2.1.2 Strong Growth for Clinical Manufacturing Revenue
8.2.1.3 Catalent Expanding its Clinical Supply Services
8.2.2 Patheon
8.2.2.1 Patheon – Global leader in Pharmaceutical Development Services
8.2.2.2 Patheon Completed 618 Clinical Projects in 2014
8.2.3 Almac Group: Manufacturing, Packaging and Logistics Services
8.2.3.1 Clinical Trial Supply and Management Solutions
8.2.3.2 Almac Opens New Facilities to Expand its Clinical Trial Expertise
8.3 The Role of CROs in the Clinical Trial Supply and Logistics Market
8.3.1 Parexel International
8.3.1.1 Parexel’s Clinical Trial Supply and Logistics Services
8.3.1.2 Parexel Expands Worldwide
8.4 Other Leading Companies in the Clinical Trial Supply and Logistics Market 2015
8.4.1 Fisher Clinical Services (FCS)
8.4.1.1 FCS Offers Manufacturing, Packaging, Storage and Distribution Services
8.4.1.2 Fisher BioServices: Clinical Logistics for the Cell Therapy Industry
8.4.2 Packaging Coordinators Inc. (PCI)

9. Research Interviews from Our Survey
9.1 Ariette van Strien, Chief Commercial Officer, Marken
9.1.1 Marken
9.1.2 Major Changes in The Clinical Trial Supply and Logistics Market
9.1.3 The Landscape of Emerging Markets
9.1.4 Opportunities and Plans of Marken’s Network
9.2 Thaddeus O. Mac Krell, Vice President, European Commercial Operations, Sales & Marketing, Movianto
9.2.1 Movianto
9.2.2 Clinical Trial Supply and Logistics Market
9.2.3 Cold Chain Services
9.2.4 Movianto’s Future Move
9.3 Amy Lombardi, Group Product Manager and Bernie Clark, Strategic Marketing Director, Catalent’s Clinical Supply Services Business
9.3.1 Clinical Trial Supply and Logistics Market
9.3.2 Cold Chain Services
9.3.3 Emerging Market Outlook
9.3.4 Catalent’s Plan for the Future

10. Conclusions of Our Study
10.1 The Clinical Trial Supply and Logistics Market in 2015
10.2 Outlook for the Market 2016-2026
10.3 Growing Demand for Clinical Logistics in Emerging Countries
10.4 Technology and Innovation to Drive Outsourcing


【レポート販売概要】

■ タイトル:製薬産業向け治験サプライ及び物流の世界市場2016-2026
■ 英文:Clinical Trial Supply and Logistics Market for Pharma 2016-2026
■ 発行日:2016年3月
■ 調査会社:visiongain
■ 商品コード:VGAIN6041530
■ 調査対象地域:グローバル
  • 世界のSaaS基盤ビジネス分析市場動向(2012-2016)
    TechNavio's analysts forecast the Global SaaS-based Business Analytics market to grow at a CAGR of 24.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to improve efficiency and reduce overall operational costs. The Global SaaS-based Business Analytics market has also been witnessing the emergence of advanced analytics. However, the presenc …
  • 動物用画像診断装置の世界市場2015-2022
    According to Stratistics MRC, the Global Veterinary Imaging Market is valued at $1.98 billion in 2015 and is expected to grow at a CAGR of 7.1% to reach $3.21 billion by 2022. Increasing demand for diagnostic equipment for the appropriate care of pets is one of the key factors fueling the market growth. Moreover, shift towards oil drilling activities by exploration and production companies due to …
  • うっ血性心不全(CHF)治療装置の世界市場分析:製品別(心室補助装置、カウンター脈動装置、植込み型除細動器、心臓ペースメーカー、心臓再同期療法)、セグメント予測
    The congestive heart failure (CHF) treatment devices market is expected to reach USD 32.0 billion by 2024, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs. Fa …
  • 世界の排煙脱硫装置(FGD)市場
    About Flue Gas Desulfurizer Flue Gas Desulfurizer (FGD) is a system for removing sulfur dioxide from flue gas, which is produced as an exhaust from waste incineration plants, power plants fueled by fossil fuels such as coal, or oil and chemical plants. Various methods are used for achieving this process. This report involves FGD using dry lime, wet calcium, and other methods such as ammonia scrubb …
  • スーパー崩壊剤の世界市場:クロスカルメロースナトリウム、クロスポビドン、デンプングリコール酸ナトリウム、イオン交換樹脂
    The global superdisintegrants market is expected to reach USD 416.5 Million by 2021 from USD 286.8 Million in 2016, at a CAGR of 7.8% during the forecast period of 2016 to 2021. Growing generic drugs market, growing population of geriatric and paediatric patients, and emergence of new superdisintegrants for the pharmaceutical industry are factors driving the growth of the market. However, factors …
  • マイクロディスプレイの世界市場2016-2020
    About the Microdisplay Market Microdisplays are microminiaturized displays having a screen size of less than 25 millimeters (screen size refers to the diagonal distance from one corner to the opposite corner of the screen). They are high-density screens with high resolution and are used in magnified display systems. Microdisplays are often used in conjunction with magnifying optics because of thei …
  • 世界の原子力発電所及び装置市場(~2019)
    This report estimates the nuclear power and equipment market in terms of value. The market is estimated on the basis of the global upcoming nuclear power plant countfor the period 2012 to 2019.The market value is estimated on the basis of the capital expenditures ofthe various types of nuclear power plants. The report estimates the market size of nuclear power reactorsfor products comprising PWR a …
  • 蓄膿(Empyema):世界の治験レビュー2014年下半期版
    Empyema Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Empyema Global Clinical Trials Review, H2, 2014" provides data on the Empyema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Empyema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
  • リン化アルミニウムの世界市場
    Aluminium phosphide (CAS 20859-73-8) Market Research Report 2013 presents comprehensive data on aluminium phosphide markets globally and regionally (Europe, Asia, North America etc.) The Aluminium phosphide (CAS 20859-73-8) Market Research Report 2013 includes aluminium phosphide description, covers its application areas and related patterns. It overviews aluminium phosphide market, names aluminiu …
  • ハイブリッド自転車の世界市場2019-2023
    About this market There has been a rapid consumer shift worldwide from motor vehicles to bicycles as a feasible mode of city transport, especially for work commute. Hybrid bicycles offer a better balance of control and speed on roads compared with mountain bikes and road bikes. The betterment of cycling infrastructure with high emphasis on establishing dedicated bicycle lanes, crossings, bicycle r …
  • 世界のカプロラクタム(ナイロン6繊維/ナイロン6樹脂用途)市場
    About Caprolactam Caprolactam is an intermediate polymer that is used in the production of nylon 6 fibers and nylon 6 resins, which accounts for 98 percent of the total caprolactam produced. Nylon 6 fibers are used in textiles, carpets, and industrial yarns while nylon 6 resins are used as engineering plastics in the Automotive, Films and Coatings, Wire and Cable, and Electrical industries. Caprol …
  • ヘルスケアITアウトソーシングの世界市場2015-2019
    About healthcare IT outsourcing Healthcare IT outsourcing is the process of contracting IT-related services in hospitals and clinical laboratories to a third-party service provider to reduce operational costs and improve efficiency. IT application and infrastructure outsourcing are the two functions that are frequently outsourced by hospitals and clinical laboratories. Economic condition, whether …
  • 世界のポリマー・フォーム市場:ポリウレタン、ポリスチレン、ポリ塩化ビニル、ポリオレフィン、フェノール樹脂、メラミンなど
    Polymer foam market is dominated by Asia-Pacific region securing more than one third of global market share. China was leading the demand for polymer foam in Asia-Pacific region, growing with the highest CAGR. Europe and North America were following the Asia-Pacific polymer foam market and were home to the largest players of industry such as BASF SE (Germany) and INEOS Styrenics (Switzerland). Bui …
  • 手術室用装置/用品の世界市場:麻酔機械、手術台、電気手術ユニット、マルチパラメータ患者モニタ、手術用画像デバイス、手術室照明
    The operating room equipment & supplies market is expected to reach USD 29.15 Billion in 2020 from USD 24.31 Billion in 2015, growing at a CAGR of 3.7%. The global market is segmented on the basis of product, type, and end user. By product, the market is categorized into operating room supplies and operating room equipment. The operating room supplies are estimated to account for the largest share …
  • Siponimod (Multiple Sclerosis):市場予測と分析(~2022)
    Siponimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Siponimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central n …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。